About 3 results found for searched term "BMS 453" (0.12 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5125 | BMS-687453 | PPAR |
| Bms-687453 is an effective and selective PPARα agonist with EC50 and IC50 of 10 nM and 260 nM for human PPARα, respectively. The EC50 and IC50 values were 4100 nM and >15000 nM, respectively. | ||
| M6100 | Nivolumab | PD-1/PD-L1 |
| BMS-936558, ONO-4538, MDX-1106；Opdivo | ||
| Nivolumab (nabumab) is a fully humanized IgG4 monoclonal antibody against PD-1. It has immune checkpoint inhibitory activity and antitumor activity; MW: 143.597 KD.(for human-derived mice). | ||
| M6518 | BMS 453 | Others |
| BMS 453 is a synthetic retinoid and RARβ agonist; also RARα and RARγ antagonist. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
